SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0000936392-07-000206
Filing Date
2007-03-16
Accepted
2007-03-16 13:15:01
Documents
12
Period of Report
2006-12-31

Document Format Files

Seq Description Document Type Size
1 FORM 10-K DATED DECEMBER 31, 2006 a28325e10vk.htm 10-K 1171633
2 EXHIBIT 10.301 a28325exv10w301.htm EX-10.301 86099
3 EXHIBIT 10.302 a28325exv10w302.htm EX-10.302 147701
4 EXHIBIT 10.303 a28325exv10w303.htm EX-10.303 75145
5 EXHIBIT 10.308 a28325exv10w308.htm EX-10.308 13281
6 EXHIBIT 10.309 a28325exv10w309.htm EX-10.309 39744
7 EXHIBIT 31.1 a28325exv31w1.htm EX-31.1 6199
8 EXHIBIT 31.2 a28325exv31w2.htm EX-31.2 6201
9 EXHIBIT 32.1 a28325exv32w1.htm EX-32.1 3311
10 EXHIBIT 32.2 a28325exv32w2.htm EX-32.2 3318
11 GRAPHIC a28325a2832501.gif GRAPHIC 8077
12 GRAPHIC a28325a2832500.gif GRAPHIC 7364
  Complete submission text file 0000936392-07-000206.txt   1575624
Mailing Address 10275 SCIENCE CENTER DRIVE SAN DIEGO CA 92121-1117
Business Address 10275 SCIENCE CENTER DRIVE SAN DIEGO CA 92121-1117 8585507500
LIGAND PHARMACEUTICALS INC (Filer) CIK: 0000886163 (see all company filings)

IRS No.: 770160744 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-K | Act: 34 | File No.: 001-33093 | Film No.: 07699068
SIC: 2834 Pharmaceutical Preparations